CARMEN YUNG: Open Payments
NPI 1003475450 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,148 in 103 payments from 12 companies in 2025. Trend: 2023 $1,257 · 2024 $2,503 · 2025 $2,148
Food & beverage: $2,148
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $547 |
| ABBVIE INC. | 17 | $470 |
| Lilly USA, LLC | 15 | $271 |
| Aimmune Therapeutics, Inc. | 10 | $243 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $156 |
| Madrigal Pharmaceuticals | 7 | $150 |
| Ardelyx, Inc. | 7 | $143 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| Intercept Pharmaceuticals, Inc. | 2 | $36 |
| Ipsen Biopharmaceuticals, Inc | 1 | $30 |
Products named: TREMFYA, OMVOH, SKYRIZI, ZENPEP, RINVOQ, REZDIFFRA, IBSRELA, ENTYVIO.
Industry payments across CA — which companies pay providers there.
